Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Open Access
- 14 February 2012
- journal article
- research article
- Published by Elsevier
- Vol. 21 (2) , 227-239
- https://doi.org/10.1016/j.ccr.2011.12.024
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and ActivityCancer Cell, 2011
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersClinical Proteomics, 2010
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in TumorsPublished by Elsevier ,2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironmentBreast Cancer Research and Treatment, 2009
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K SignalingCancer Cell, 2009
- Unraveling the microenvironmental influences on the normal mammary gland and breast cancerSeminars in Cancer Biology, 2008
- Pathways to tamoxifen resistanceCancer Letters, 2007
- The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expressionPublished by Wiley ,2007